Mutations in the dysferlin gene (DYSF) lead to a complete or partial absence of the dysferlin protein in skeletal muscles and are at the origin of dysferlinopathies, a heterogeneous group of rare autosomal recessive inherited neuromuscular disorders. As a step towards a better understanding of the DYSF mutational spectrum, and towards possible inclusion of patients in future therapeutic clinical trials, we set up the Universal Mutation Database for Dysferlin (UMD-DYSF), a Locus-Specific Database developed with the UMD® software. The main objective of UMD-DYSF is to provide an updated compilation of mutational data and relevant interactive tools for the analysis of DYSF sequence variants, for diagnostic and research purposes. In particular, specific algorithms can facilitate the interpretation of newly identified intronic, missense- or isosemantic-exonic sequence variants, a problem encountered recurrently during genetic diagnosis in dysferlinopathies. UMD-DYSF v1.0 is freely accessible at www.umd.be/DYSF/. It contains a total of 742 mutational entries corresponding to 266 different disease-causing mutations identified in 558 patients worldwide diagnosed with dysferlinopathy. This article presents for the first time a comprehensive analysis of the dysferlin mutational spectrum based on all compiled DYSF disease-causing mutations reported in the literature to date, and using the main bioinformatics tools offered in UMD-DYSF.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/humu.22015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cryo-EM structures of the membrane repair protein dysferlin.
Nat Commun
November 2024
Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University College of Medicine, Columbus, USA.
Plasma membrane repair in response to damage is essential for cell viability. The ferlin family protein dysferlin plays a key role in Ca-dependent membrane repair in striated muscles. Mutations in dysferlin lead to a spectrum of diseases known as dysferlinopathies.
View Article and Find Full Text PDFClinical Presentation, Diagnosis, and Genetic Insights of Miyoshi Myopathy: A Case Report and Literature Review.
Cureus
September 2024
Neurology, Marek Kulma Praktyka Lekarska, Gorzkowice, POL.
Article Synopsis
- Miyoshi myopathy (MM) is a rare genetic disorder due to mutations in the dysferlin gene, linked to muscle degeneration and recognized as the same disease as Lower Girdle Muscular Dystrophy R2 (LGMD2B).
- A 44-year-old male patient started experiencing symptoms at 19, including difficulties with stairs and toe-standing, leading to observable muscle atrophy and walking issues over the years.
- The diagnosis was confirmed through genetic testing, revealing a mutation in the DYSF gene, and highlights the critical role of genetic diagnostics and the need for further research in muscular dystrophies.*
Comprehensive Proteomic Analysis of Dysferlinopathy Unveiling Molecular Mechanisms and Biomarkers Linked to Pathological Progression.
CNS Neurosci Ther
October 2024
Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
Article Synopsis
- This study aimed to enhance the understanding of dysferlinopathy by using high-resolution proteomics to analyze muscle biopsies and link protein expression changes with musculoskeletal pathology.
- Researchers examined tissue samples from 15 dysferlinopathy patients and age-matched controls, employing advanced techniques like TMT-labeled LC-MS/MS for proteomic profiling and various network analyses.
- The findings revealed 1600 differentially expressed proteins associated with dysferlinopathy, highlighting dysregulated pathways related to metabolism, immune response, and muscle function, and identifying key proteins linked to disease severity and muscle damage.
Can we differentiate patients with dysferlinopathies and inflammatory myopathies by ultrasound? A discriminant analysis study.
Rheumatol Int
December 2024
Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, México.
Article Synopsis
- Idiopathic inflammatory myopathies (IIM) and dysferlinopathies both cause muscle inflammation and weakness but have different underlying causes and implications.
- A study analyzed ultrasound differences in muscle abnormalities between 11 patients with dysferlinopathies and 11 patients with IIM, focusing on 20 muscles to see if ultrasound could aid in diagnosis.
- Results showed that specific muscle sets (biceps, quadriceps, gastrocnemius) could accurately distinguish between the two conditions, suggesting ultrasound is a valuable diagnostic tool for muscle diseases.
Miyoshi Muscular Dystrophy Type 1 is a rare autosomal recessive myopathy caused by mutations in the gene. This disease presents with progressive distal lower limb weakness, such as gastrocnemius and soleus muscles resulting in difficulty standing on tiptoes, walking, and climbing stairs. We describe a family consisting of 6 siblings, 2 affected males, 1 affected female, 1 affected-death female, and 2 unaffected females.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!